Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 43, 2014 - Issue 7
266
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Activation of α7nAChR by Nicotine Reduced the Th17 Response in CD4+T Lymphocytes

, , , &
 

Abstract

Background: nAChRs play an important role in the regulation and modulation of immune cell proliferation, differentiation, migration and cell-cell interactions. The present study was to characterize the expression of α7nAChR on human peripheral blood mononuclear cells (hPBMC) and CD4+T lymphocytes, and to explore the change of Th17 expression after activation of α7nAChR on human CD4+T lymphocytes.

Methods: A Ficoll gradient was used to separate hPBMC from whole blood, and then CD4+T lymphocytes were isolated by magnetic bead separation. The expression of α7nAChR on PBMC and CD4+T lymphocytes was analyzed using flow cytometry before and after stimulation with phytohemagglutinin (PHA). The effect of α7nAChR stimulation by nicotine or inhibition by α-bungarotoxin (α-BTX), as well as Th17 expression on the phenotype of CD4+T cells was evaluated using flow cytometric analysis.

Results: The percentage of CD4+T cells in reduced PBMC, while the expression of α7nAChR increased when cells were stimulated by nicotine. This effect vanished when co-treated with nicotine and α-BTX. α7nAChR was found to expressed in about 90% of CD4+T cells. However, α7nAChR expression reduced to 80% on CD4+T cells after stimulation with PHA for 24 h. Stimulation of α7nAChR with nicotine increased the expression of Th17 cells, and this upregulation reduced when AChRα7 was inhibited by α-BTX.

Conclusion: α7nAChR was ubiquitously expressed by CD4+T lymphocytes, which was correlated with the cell activation status. Meanwhile, activation of nAChRα7 by nicotine in CD4 cells reduced the Th17 response.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.